Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
doi: 10.3389/fimmu.2025.1626973 Received 12 May 2025 Accepted 23 June 2025 Published 04 July 2025 Volume 16 - 2025 Edited by Junji Xing, Houston Methodist Research Institute, United States Reviewed by Jong-Hyung Lim, University of Pennsylvania, United States Cuncai Guo, Washington University in St
doi: 10.1207/s15327914nc5002_11 94 Saavedra-LeosMZJordan-AlejandreEPuente-RiveraJSilva-CzaresMB
Users commonly report reduced body fat and increased lean muscle mass, especially when combined with consistent strength training
Abstract GLP-1 receptor agonists (GLP-1RA) and SGLT2 inhibitors (SGLT2i) have been associated with improved glycemic control, body weight loss and favorable changes in cardiovascular risk factors and outcomes
US$ 21.52
US$ 24.83
US$ 27.18
